Stifel Reiterates Hold Rating on Aclaris Therapeutis (ACRS)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- S&P 500 up, Nasdaq at record high as megacap tech stocks rise
- Oil slips on rise in Middle East crude exports and G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
| (NASDAQ: ACRS) | Delayed: 4.30 -0.09 (2.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.39 | 52 Week High | $33.88 | |||
| Open | $4.34 | 52 Week Low | $14.12 | |||
| Day High | $4.34 | P/E | N/A | |||
| Day Low | $4.07 | EPS | $0.00 | |||
| Volume | 4,448,730 | |||||
